COMBINED TEST
![ico-perche-fare-test-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-perche-fare-test-gine.png)
Why get tested?
The test, together with the measurement of the nuchal translucency (NT) and the clinical-anamnestic data of the pregnant woman, allows to evaluate the risk of a fetus presenting chromosomal abnormalities.
The test is suitable for all pregnant women and, in particular, for women over the age of 35 who have an increased risk of having a fetus affected by trisomy 21, 13 or 18.
![ico-cosa-vede-test-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-cosa-vede-test-gine.png)
What the test detects
The test quantifies PAPP-A and free-beta-hCG proteins.
![ico-cosa-producono-variazioni-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-cosa-producono-variazioni-gine.png)
What variants cause
The test identifies an increased risk of a fetus having chromosomal abnormalities.
![ico-come-svolge-test-singola-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-come-svolge-test-singola-gine.png)
How testing works
The test is performed on a maternal venous blood sample for the quantification of PAPP-A and free-beta-hCG proteins.
![ico-tempi-refertazione-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-tempi-refertazione-gine.png)
Reporting time
Results in 2-3 working days.
![ico-sensibilita-specificita-gine](https://www.personalgenomics.it/en/wp-content/uploads/sites/2/2021/04/ico-sensibilita-specificita-gine.png)
Sensitivity and specificity
Diagnostic sensibility for trisomy 21 is 90%.